2019 Q1 Form 10-K Financial Statement

#000114420419033096 Filed on June 28, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2019 2018 Q1
Revenue $14.48M $84.98M $8.850M
YoY Change 63.62% 22.64% -27.28%
Cost Of Revenue $11.91M $66.21M $6.720M
YoY Change 77.23% 28.95% -15.58%
Gross Profit $2.570M $18.78M $2.130M
YoY Change 20.66% 4.59% -49.41%
Gross Profit Margin 17.75% 22.09% 24.07%
Selling, General & Admin $2.780M $8.835M $1.690M
YoY Change 64.5% 47.18% 19.86%
% of Gross Profit 108.17% 47.05% 79.34%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $300.0K $1.256M $320.0K
YoY Change -6.25% 3.19% 10.34%
% of Gross Profit 11.67% 6.69% 15.02%
Operating Expenses $2.780M $12.43M $1.680M
YoY Change 65.48% 103.11% 18.31%
Operating Profit -$210.0K $6.349M $450.0K
YoY Change -146.67% -46.36% -83.87%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $23.80K -$30.00K
YoY Change -100.0% -175.88% 50.0%
Pretax Income -$210.0K $6.372M $420.0K
YoY Change -150.0% -46.01% -84.84%
Income Tax $10.00K $1.261M $1.400M
% Of Pretax Income 19.79% 333.33%
Net Earnings -$220.0K $5.112M -$980.0K
YoY Change -77.55% -50.89% -135.13%
Net Earnings / Revenue -1.52% 6.02% -11.07%
Basic Earnings Per Share $0.46
Diluted Earnings Per Share -$19.43K $0.45 -$99.09K
COMMON SHARES
Basic Shares Outstanding 11.33M 11.20M 9.895M shares
Diluted Shares Outstanding 11.33M

Balance Sheet

Concept 2019 Q1 2019 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $27.18M $8.598M
Short-Term Investments
Other Short-Term Assets $30.25M $30.25M $11.26M
YoY Change 168.65% 168.65% 127.47%
Inventory $21.07M $21.07M $20.29M
Prepaid Expenses
Receivables $4.020M $4.020M $5.247M
Other Receivables $0.00 $0.00 $50.00K
Total Short-Term Assets $55.35M $55.35M $36.85M
YoY Change 50.2% 50.2% 21.78%
LONG-TERM ASSETS
Property, Plant & Equipment $2.356M $2.360M $2.820M
YoY Change -16.44% -16.31% -10.78%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.540M $1.540M $3.600M
YoY Change -57.22% -57.22% 650.0%
Total Long-Term Assets $3.900M $3.900M $6.418M
YoY Change -39.23% -39.25% 76.38%
TOTAL ASSETS
Total Short-Term Assets $55.35M $55.35M $36.85M
Total Long-Term Assets $3.900M $3.900M $6.418M
Total Assets $59.25M $59.25M $43.27M
YoY Change 36.94% 36.93% 27.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.378M $3.380M $4.777M
YoY Change -29.28% -29.29% -53.41%
Accrued Expenses $1.539M $1.540M $1.175M
YoY Change 30.94% 30.51% 153.07%
Deferred Revenue
YoY Change
Short-Term Debt $650.0K $650.0K $980.0K
YoY Change -33.67% -33.67%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.586M $7.590M $7.923M
YoY Change -4.26% -4.17% -33.3%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.400M $1.400M $1.290M
YoY Change 8.53% 8.53%
Total Long-Term Liabilities $1.400M $1.400M $1.290M
YoY Change 8.53% 8.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.586M $7.590M $7.923M
Total Long-Term Liabilities $1.400M $1.400M $1.290M
Total Liabilities $8.989M $9.300M $9.211M
YoY Change -2.41% -2.31% -22.46%
SHAREHOLDERS EQUITY
Retained Earnings $34.79M $30.95M
YoY Change 12.4% 50.69%
Common Stock $11.33K $9.895K
YoY Change 14.45% 12.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $49.95M $49.95M $33.75M
YoY Change
Total Liabilities & Shareholders Equity $59.25M $59.25M $43.27M
YoY Change 36.94% 36.93% 27.65%

Cashflow Statement

Concept 2019 Q1 2019 2018 Q1
OPERATING ACTIVITIES
Net Income -$220.0K $5.112M -$980.0K
YoY Change -77.55% -50.89% -135.13%
Depreciation, Depletion And Amortization $300.0K $1.256M $320.0K
YoY Change -6.25% 3.19% 10.34%
Cash From Operating Activities -$2.150M $9.775M -$5.520M
YoY Change -61.05% 89.31% -588.5%
INVESTING ACTIVITIES
Capital Expenditures -$70.00K $791.0K -$150.0K
YoY Change -53.33% -9.9% 25.0%
Acquisitions
YoY Change
Other Investing Activities -$430.0K -$810.0K $0.00
YoY Change -338.24% -100.0%
Cash From Investing Activities -$500.0K -$1.601M -$150.0K
YoY Change 233.33% 195.85% -67.39%
FINANCING ACTIVITIES
Cash Dividend Paid $1.133M
YoY Change
Common Stock Issuance & Retirement, Net $8.930M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 70.00K 7.466M -3.090M
YoY Change -102.27% 116.67%
NET CHANGE
Cash From Operating Activities -2.150M 9.775M -5.520M
Cash From Investing Activities -500.0K -1.601M -150.0K
Cash From Financing Activities 70.00K 7.466M -3.090M
Net Change In Cash -2.580M 15.64M -8.760M
YoY Change -70.55% 93.94% -1407.46%
FREE CASH FLOW
Cash From Operating Activities -$2.150M $9.775M -$5.520M
Capital Expenditures -$70.00K $791.0K -$150.0K
Free Cash Flow -$2.080M $8.984M -$5.370M
YoY Change -61.27% 109.64% -529.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
30948006
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14440
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27182158
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8597830
CY2019Q1 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
0
CY2018Q1 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
50027
CY2019Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2630727
CY2018Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1533868
CY2019Q1 us-gaap Supplies
Supplies
443395
CY2018Q1 us-gaap Supplies
Supplies
1128079
CY2019Q1 us-gaap Assets Current
AssetsCurrent
55350892
CY2018Q1 us-gaap Assets Current
AssetsCurrent
36850286
CY2019Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
652310
CY2018Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3598280
CY2019Q1 us-gaap Assets
Assets
59251097
CY2018Q1 us-gaap Assets
Assets
43268281
CY2019Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
648711
CY2018Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
980195
CY2019Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3378258
CY2018Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
4776812
CY2019Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1539147
CY2018Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1175427
CY2019Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1164238
CY2018Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
112000
CY2019Q1 jrsh Other Payables Current
OtherPayablesCurrent
855527
CY2018Q1 jrsh Other Payables Current
OtherPayablesCurrent
878987
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
7585881
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
7923421
CY2019Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1403087
CY2018Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1288000
CY2019Q1 us-gaap Liabilities
Liabilities
8988968
CY2018Q1 us-gaap Liabilities
Liabilities
9211421
CY2019Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2018Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
11325
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
9895
CY2019Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14956767
CY2018Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2742158
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
34786735
CY2018Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-24502
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
49953126
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
33747256
CY2019Q1 us-gaap Minority Interest
MinorityInterest
309003
CY2018Q1 us-gaap Minority Interest
MinorityInterest
309604
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
50262129
CY2018Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
34056860
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
59251097
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
43268281
CY2016Q4 jrsh Percenage Of Individual Shareholder Transactions
PercenageOfIndividualShareholderTransactions
0.22
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8787500
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11325000
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9895000
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9895000
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2019Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11325000
CY2019Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2019Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
4020369
CY2018Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
5247090
CY2018Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6722646
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="color: rgb(0, 0, 0); font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; color: rgb(0, 0, 0); font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="color: rgb(0, 0, 0); font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the consolidated financial statements, in conformity with U.S. GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company&#8217;s most significant estimates include allowance for doubtful accounts, valuation of inventory reserve and useful lives of buildings and other property. Actual results could differ from these estimates.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2019Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4020369
CY2018Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5247090
CY2019Q1 jrsh Factored Accounts Receivable
FactoredAccountsReceivable
3
CY2018Q1 jrsh Factored Accounts Receivable
FactoredAccountsReceivable
470659
CY2019Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
11601262
CY2018Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
11497237
CY2019Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
1889329
CY2018Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
2073509
CY2019Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7583652
CY2019Q1 us-gaap Inventory Net
InventoryNet
21074243
CY2018Q1 us-gaap Inventory Net
InventoryNet
20293392
CY2019Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
200042
CY2018Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
217494
CY2019Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6467793
CY2018Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5238992
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2356262
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2819715
CY2019Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2019 us-gaap Revenues
Revenues
84983661
CY2018 us-gaap Revenues
Revenues
69295698
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
66206652
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
51342020
CY2019 us-gaap Gross Profit
GrossProfit
18777009
CY2018 us-gaap Gross Profit
GrossProfit
17953678
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8834547
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6002452
CY2019 us-gaap Operating Expenses
OperatingExpenses
12428435
CY2018 us-gaap Operating Expenses
OperatingExpenses
6119030
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
6348574
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
11834648
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
23802
CY2019 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="color: rgb(0, 0, 0); font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Concentrations and Credit Risk</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; background: none;"><div style="color: rgb(0, 0, 0); font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;"><div style="color: rgb(0, 0, 0); font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Credit risk</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; background: none;"><div style="color: rgb(0, 0, 0); font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="color: rgb(0, 0, 0); font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash. As of March 31, 2019, and 2018, respectively, $7,121,161 and $4,793,527 of the Company&#8217;s cash were on deposit at financial institutions in Jordan, where there currently is no rule or regulation requiring such financial institutions to maintain insurance to cover bank deposits in the event of bank failure. As of March 31, 2019, and 2018, respectively, $20,614,581 and $7,400,111 of the Company&#8217;s cash was on deposit at financial institutions in Hong Kong, which are insured by the Hong Kong Deposit Protection Board subject to certain limitations. While management believes that these financial institutions are of high credit quality, it also continually monitors their credit worthiness. As of March 31, 2019, and 2018, respectively, $98,726 and $2,472 of the Company&#8217;s cash was on deposit in the United States and are insured by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) up to $250,000.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; color: rgb(0, 0, 0); font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="color: rgb(0, 0, 0); font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounts receivable are typically unsecured and derived from revenue earned from customers, and therefore are exposed to credit risk. The risk is mitigated by the Company's assessment of its customers' creditworthiness and its ongoing monitoring of outstanding balances.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; color: rgb(0, 0, 0); font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;"><div style="color: rgb(0, 0, 0); font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Customer and vendor concentration risk</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; color: rgb(0, 0, 0); font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="color: rgb(0, 0, 0); font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prior to August 2016, substantially all of the Company&#8217;s sales were made to end-customers, through its affiliate (see Note 9), that are located primarily in the United States (see Note 12). Thereafter, the Company began selling directly to its customers. The Company&#8217;s operating results could be adversely affected by the U.S. government&#8217;s policy on exporting business, foreign exchange rate fluctuations, and change of local market conditions. The Company has a concentration of its revenues and purchases with specific customers and suppliers. For the each of the fiscal years ended March 31, 2019 and 2018, one end-customer accounted for 79% of total revenue. Including accounts receivable balances through the Company&#8217;s affiliates, as of March 31, 2019, one end-customer accounted for 96% of the total accounts receivable balance. As of March 31, 2018, two end-customers separately accounted for 57% and 22% of the total accounts receivable balance</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; background: none;"><div style="white-space: pre-line; color: rgb(0, 0, 0); font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="color: rgb(0, 0, 0); font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the fiscal year ended March 31, 2019, the Company purchased approximately 19%, 12% and 11% of its raw materials from three major suppliers. For the fiscal year ended March 31, 2018 the company purchased approximately 43% and 18% of its raw materials from two major suppliers. As of March 31, 2019, accounts payable to three major suppliers separately accounted for 40%, 20% and 14% of the total accounts payable balance. As of March 31, 2018, there was a net prepaid balance to one major supplier totaling $874,591.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; color: rgb(0, 0, 0); font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="color: rgb(0, 0, 0); font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A loss of any of these customers or suppliers could adversely affect the operating results or cash flows of the Company.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-31369
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6372376
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11803279
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1260861
CY2019Q1 us-gaap Area Of Land
AreaOfLand
4800
CY2019 us-gaap Income Tax Holiday Description
IncomeTaxHolidayDescription
In accordance with the Investment Encouragement Law, Jerash Garments' export sales to overseas customers were entitled to a 100% income tax exemption for a period of 10 years commencing at the first day of production. This exemption had been extended for five years until December 31, 2018.
CY2019Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8624013
CY2018Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7841213
CY2019 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-754
CY2018 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-6838
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-10215
CY2018 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
16262
CY2019 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
5121730
CY2018 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
10387017
CY2019 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-601
CY2018 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-6993
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5122331
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10394010
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11199630
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9735651
CY2019Q1 us-gaap Retained Earnings Appropriated
RetainedEarningsAppropriated
212739
CY2018Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1430000
CY2018Q1 jrsh Marketing Services And Advisoryamount
MarketingServicesAndAdvisoryamount
300000
CY2018Q1 jrsh Marketing Services And Advisoryamount
MarketingServicesAndAdvisoryamount
300000
CY2019 jrsh Consulting Fees
ConsultingFees
300000
CY2018 jrsh Consulting Fees
ConsultingFees
75000
CY2019 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1528500
CY2018 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1274606
CY2019 us-gaap Net Income Loss
NetIncomeLoss
5112269
CY2018 us-gaap Net Income Loss
NetIncomeLoss
10410117
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.46
CY2018Q1 us-gaap Retained Earnings Appropriated
RetainedEarningsAppropriated
71699
CY2019 us-gaap Profit Loss
ProfitLoss
5111515
CY2018 us-gaap Profit Loss
ProfitLoss
10403279
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1255820
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1216973
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
3593888
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
116578
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1229239
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2472680
CY2017Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
22017790
CY2018 jrsh Reverse Recapitalization
ReverseRecapitalization
1000
CY2018 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1534475
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3593888
CY2019 us-gaap Dividends
Dividends
1132500
CY2018 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
444475
CY2019 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1387879
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11330310
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9735651
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
23802
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-31369
CY2017Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2018Q4 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.05
CY2018Q4 us-gaap Dividends
Dividends
566250
CY2018Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1484250
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
150000
CY2018Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.12
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1139500
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.88
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1139500
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.88
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
193955
CY2019Q1 jrsh Percentage Of Flate Fee
PercentageOfFlateFee
0.0035
CY2019 us-gaap Line Of Credit Facility Expiration Period
LineOfCreditFacilityExpirationPeriod
P120D
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5112000
CY2019 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
130680
CY2019Q1 jrsh Deposit Assets Noncurrent
DepositAssetsNoncurrent
810172
CY2018Q1 jrsh Deposit Assets Noncurrent
DepositAssetsNoncurrent
0
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10410000
CY2018 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.07
CY2019Q1 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
81461
CY2018Q1 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
0
CY2019Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
2567325
CY2018Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
1400000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-5205168
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-594594
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
11577544
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
12397873
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.07
CY2019Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.05
CY2019Q1 us-gaap Dividends
Dividends
566250
CY2018Q1 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
874591
CY2018 us-gaap Income Tax Reconciliation Repatriation Of Foreign Earnings
IncomeTaxReconciliationRepatriationOfForeignEarnings
1400000
CY2019 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-50047
CY2018 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-2293190
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
770720
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1151531
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1404198
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
470441
CY2019 us-gaap Increase Decrease In Prepaid Supplies
IncreaseDecreaseInPrepaidSupplies
-685197
CY2018 us-gaap Increase Decrease In Prepaid Supplies
IncreaseDecreaseInPrepaidSupplies
1128320
CY2019 jrsh Increase Decrease In Deferred Tax Assets
IncreaseDecreaseInDeferredTaxAssets
81461
CY2018 jrsh Increase Decrease In Deferred Tax Assets
IncreaseDecreaseInDeferredTaxAssets
0
CY2019 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-23888
CY2018 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-282472
CY2019 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
1167322
CY2018 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
1400000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9775265
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5163596
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
791001
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
877944
CY2019 us-gaap Payments For Deposits
PaymentsForDeposits
380000
CY2018 us-gaap Payments For Deposits
PaymentsForDeposits
0
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1601114
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-541198
CY2019 us-gaap Payments Of Dividends
PaymentsOfDividends
1132500
CY2018 us-gaap Payments Of Dividends
PaymentsOfDividends
0
CY2019 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
-331876
CY2018 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
980403
CY2019 jrsh Due From Shareholders Classified As Financing Activities
DueFromShareholdersClassifiedAsFinancingActivities
0
CY2018 jrsh Due From Shareholders Classified As Financing Activities
DueFromShareholdersClassifiedAsFinancingActivities
692500
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8930300
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2019 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
30
CY2018 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0
CY2019 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0
CY2018 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
1772845
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7465954
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3445748
CY2019 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1747
CY2018 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-4797
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
15638358
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8063349
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
175000
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2019 us-gaap Interest Paid Net
InterestPaidNet
90867
CY2018 us-gaap Interest Paid Net
InterestPaidNet
27292
CY2019 jrsh Warrants Issued To Placement Agent With Private Placement
WarrantsIssuedToPlacementAgentWithPrivatePlacement
160732
CY2018 jrsh Warrants Issued To Placement Agent With Private Placement
WarrantsIssuedToPlacementAgentWithPrivatePlacement
161926
CY2019 jrsh Prepaid Stock Issuance Cost Netted With Proceeds From Private Placement
PrepaidStockIssuanceCostNettedWithProceedsFromPrivatePlacement
308179
CY2018 jrsh Prepaid Stock Issuance Cost Netted With Proceeds From Private Placement
PrepaidStockIssuanceCostNettedWithProceedsFromPrivatePlacement
239105
CY2019Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
81461
CY2019Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
81461
CY2019 us-gaap Income Tax Holiday Aggregate Dollar Amount
IncomeTaxHolidayAggregateDollarAmount
1623717
CY2019 us-gaap Income Tax Holiday Income Tax Benefits Per Share
IncomeTaxHolidayIncomeTaxBenefitsPerShare
0.14
CY2018Q4 jrsh Provision Of Transition Tax Foreign Subsidiaries
ProvisionOfTransitionTaxForeignSubsidiaries
1400000
CY2018 jrsh Transition Tax Due Period
TransitionTaxDuePeriod
P8Y
CY2018 jrsh Stock Based Compensation Expense For The Warrant Issued To The Board Observer
StockBasedCompensationExpenseForTheWarrantIssuedToTheBoardObserver
116578
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8622121
CY2019 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
30
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1400533
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5472312
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
363037
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
711332
CY2019 us-gaap Proceeds From Payments For Long Term Loans For Related Parties
ProceedsFromPaymentsForLongTermLoansForRelatedParties
0
CY2018 us-gaap Proceeds From Payments For Long Term Loans For Related Parties
ProceedsFromPaymentsForLongTermLoansForRelatedParties
336746
CY2019Q1 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.05
CY2019 jrsh Statutory Reserve Value
StatutoryReserveValue
0
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.198
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.119
CY2019 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
4200000
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2018 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
3723692
CY2019Q1 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
20200000
CY2019Q2 us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2019-06-05
CY2019Q2 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2019-05-28
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
jrsh Percentage Of Sales Tax
PercentageOfSalesTax
0.16
CY2019 jrsh Retained Earnings Appropriation Description
RetainedEarningsAppropriationDescription
Appropriations to the statutory reserve are required to be 10% of net income until the reserve is equal to 100% of the entity&#8217;s share capital.
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P10Y
CY2019 us-gaap Related Party Transaction Description Of Transaction
RelatedPartyTransactionDescriptionOfTransaction
Sales / Purchases Lease
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27834468
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12196110
CY2017Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4132761
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-03-31
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Entity Registrant Name
EntityRegistrantName
Jerash Holdings (US), Inc.
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0001696558
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2018Q3 dei Entity Public Float
EntityPublicFloat
16271093
CY2019 dei Trading Symbol
TradingSymbol
JRSH
CY2019Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11325000
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2019 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2019 dei Entity Small Business
EntitySmallBusiness
true
CY2019 jrsh Payments To Acquire Long Term Deposits
PaymentsToAcquireLongTermDeposits
430113
CY2018 jrsh Payments To Acquire Long Term Deposits
PaymentsToAcquireLongTermDeposits
0
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
0
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
36778
CY2018 jrsh Income Tax Reconciliation Global Intangible Low Taxed Income
IncomeTaxReconciliationGlobalIntangibleLowTaxedIncome
0
CY2018 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
0
CY2018 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-3760470
CY2018 jrsh Income Tax Reconciliation Provision To Return Adjustments
IncomeTaxReconciliationProvisionToReturnAdjustments
0
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1338199
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
40
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
692749
CY2019 jrsh Income Tax Reconciliation Global Intangible Low Taxed Income
IncomeTaxReconciliationGlobalIntangibleLowTaxedIncome
1381950
CY2019 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
31307
CY2019 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-2391024
CY2019 jrsh Income Tax Reconciliation Provision To Return Adjustments
IncomeTaxReconciliationProvisionToReturnAdjustments
270254
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1400000
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1302022
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
40
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
40260
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1400000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1342322
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1400000
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-81461
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-81461
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2018Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
0
CY2018Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2019 us-gaap Income Tax Reconciliation Repatriation Of Foreign Earnings
IncomeTaxReconciliationRepatriationOfForeignEarnings
0
CY2019Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
867837
CY2019Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
242836
CY2019Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
220657
CY2019Q1 us-gaap Operating Leases Future Minimum Payments Due In Four And Five Years
OperatingLeasesFutureMinimumPaymentsDueInFourAndFiveYears
176300
CY2019Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1507630
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019 dei Security12b Title
Security12bTitle
Common Stock
CY2019 dei Security Exchange Name
SecurityExchangeName
NASDAQ

Files In Submission

Name View Source Status
0001144204-19-033096-index-headers.html Edgar Link pending
0001144204-19-033096-index.html Edgar Link pending
0001144204-19-033096.txt Edgar Link pending
0001144204-19-033096-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
image_002.jpg Edgar Link pending
jrsh-20190331.xml Edgar Link completed
jrsh-20190331.xsd Edgar Link pending
jrsh-20190331_cal.xml Edgar Link unprocessable
jrsh-20190331_def.xml Edgar Link unprocessable
jrsh-20190331_lab.xml Edgar Link unprocessable
jrsh-20190331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv523928_10k.htm Edgar Link pending
tv523928_ex10-22.htm Edgar Link pending
tv523928_ex10-22img01.jpg Edgar Link pending
tv523928_ex10-23.htm Edgar Link pending
tv523928_ex10-23img01.jpg Edgar Link pending
tv523928_ex10-5.htm Edgar Link pending
tv523928_ex23-1.htm Edgar Link pending
tv523928_ex31-1.htm Edgar Link pending
tv523928_ex31-2.htm Edgar Link pending
tv523928_ex32-1.htm Edgar Link pending
tv523928_ex32-2.htm Edgar Link pending
tv523928_ex4-1.htm Edgar Link pending
tv523928_img1.jpg Edgar Link pending